High-dose methotrexate-associated acute renal failure may be an avoidable complication

Pediatric Hematology and Oncology

Volumn 23, Issue 1, 2006, Pages 51-57

  Fong, Cheuk Ming ^a   Lee, Anselm C W ^a  

^a TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

Acute; Acute lymphoblastic leukemia; Chemically induced; Contrast media; Iopamidol; Kidney diseases; Kidney failure; Methotrexate

Indexed keywords

ASPARAGINASE; CONTRAST MEDIUM; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; FOLINIC ACID; IOPAMIDOL; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ACUTE KIDNEY FAILURE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALKALINIZATION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; DRUG MEGADOSE; HUMAN; KIDNEY FUNCTION; MALE; RETROSPECTIVE STUDY; RISK FACTOR;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; HUMANS; KIDNEY FAILURE, ACUTE; LEUCOVORIN; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; METHOTREXATE; TREATMENT OUTCOME;

EID: 28844472954     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010500313421     Document Type: Article

References (24)

1. Pitman SW, Frei E III. Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokineucs in the CNS; and use in CNS non-Hodgkin's lymphoma. Cancer Treat Rep. 1977;61:695-701.
2. Ahmad S, Shen FH, Bleyer WA. Methotrexate-induced renal failure and ineffectiveness of peritoneal dialysis. Arch Intern Med. 1978;138:1146-1147.
3. Bouffet E, Frappaz D, Laville M, et al. Charcoal haemoperfusion and methotrexate toxicity. Lancet. 1986;1:1497.
4. Widemann BC, Balis FM, Kempf-Bielack B, et al. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma: incidence, treatment, and outcome. Cancer. 2004;100:2222-2232.
5. International Berlin-Frankfurt-Muenster Study Group. ALL IC-BFM 2002: a randomised trial of the I-BFM-SG for the management of childhood non-B acute lymphoblastic leukemia. Hannover: I-BFM-SG, 2002.
6. Perazella MA. Crystal-induced acute renal failure. Am J Med. 1999;106:459-465.
7. Jacobs SA, Stoller RG, Chabner BA, Johns DG. 7-Hydroxymethotrexate as a urinary metabolite in human subjects and Rhesus monkeys receiving high dose methotrexate. J Clin Invest. 1976;57:534-538.
8. Rubnitz JE, Relling MV, Harrison PL, et al. Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemia. Leukemia. 1998;12:1176-1181.
9. Bernini JC, Fort DW, Griener JC, Kane BJ, Chappell WB, Kamen BA. Aminophylline for methotrexate-induced neurotoxicity. Lancet. 1995;345:544-547.
10. Peyriere H, Poiree M, Cociglio M, Margueritte G, Hansel S, Hillaire-Buys D. Reversal of neurologic disturbances related to high-dose methotrexate by aminophylline. Med Pediatr Oncol. 2001;36:662-664.
11. 2 rescue in a patient with high dose methotrexate-induced nephrotoxicity. Cancer. 1995;76:521-526.
12. Thierry FX, Vernier I, Dueymes JM, et al. Acute renal failure after high-dose methotrexate therapy: role of hemodialysis and plasma exchange in methotrexate removal. Nephron. 1989;51:416-417.
13. Kawabata K, Makino H, Nagake Y, et al. A case of methotrexate-induced acute renal failure successfully treated with plasma perfusion and sequential hemodialysis. Nephron 1995;71:233-234.
14. Krackhardt A, Schwartz S, Korfel A, Thiel E. Carboxypeptidase G2 resuce in a 79-year-old patient with cranial lymphoma after high-dose methotrexate induced acute renal failure. Leukemia Lymph. 1999;35:631-635.
15. van den Bongard HJ, Mathot RA, Boogerd W, et al. Successful rescue with leucovorin and thymidine in a patient with high-dose methotrexate induced acute renal failure. Cancer Chemother Pharmacol. 2001;47:237-240.
16. Greil J, Wyss PA, Ludwig K, et al. Continuous plasma resin perfusion for detoxification of methotrexate. Eur J Pediatr. 1997;156:933-936.
17. Kepka L, de Lassence A, Ribrag V, et al. Successful rescue in a patient with high dose methotrexate-induced nephrotoxicity and acute renal failure. Leukemia Lymph. 1998;29:205-209.
18. Maiche AG. Acute renal failure due to concomitant action of methotrexate and indomethacin. Lancet. 1986;1:1390.
19. Peyriere H, Cociglio M, Margueritte G, Vallat C, Blayac JP, Hillaire-Buys D. Optimal management of methotrexate intoxication in a child with osteosarcoma. Ann Pharmacother. 2004;36:422-427.
20. Maiche AG, Lappalainen K, Teerenhovi L. Renal insufficiency in patients treated with high dose methotrexate. Acta Oncol. 1988;27:73-74.
21. Crews KR, Liu T, Rodriguez-Galindo C, et al. High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma. Cancer. 2004;100:1724-1733.
22. Quader MA, Sawmiller C, Sumpio BA. Contrast-induced nephropathy: review of incidence and pathophysiology. Ann Vasc Surg. 1998;12:612-620.
23. Haight AE, Kaste SC, Goloubeva OG, Xiong XP, Bowman LC. Nephrotoxicity of iopamidol in pediatric, adolescent, and young adult patients who have undergone allogeneic bone marrow transplantation. Radiology. 2003;226:399-404.
24. 2 rescue in patients with methotrexate intoxication and renal failure. Br J Cancer. 2005;92:480-487.